Abstract Title:

Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice.

Abstract Source:

Antimicrob Agents Chemother. 2003 Dec;47(12):3982-4. PMID: 14638516

Abstract Author(s):

Xavier Haristoy, Karine Angioi-Duprez, Adrien Duprez, Alain Lozniewski

Article Affiliation:

Laboratoire de Bactériologie-Virologie, UMR CNRS 75-65, Faculté de Médecine, Université Henri-Poincaré, Vandaeuvre-les-Nancy, France.


Sulforaphane, an isothiocyanate abundant in the form of its glucosinolate precursor in broccoli sprouts, has shown in vitro activity against Helicobacter pylori. We evaluated the effect of sulforaphane in vivo against this bacterium by using human gastric xenografts in nude mice. H. pylori was completely eradicated in 8 of the 11 sulforaphane-treated grafts. This result suggests that sulforaphane might be beneficial in the treatment of H. pylori-infected individuals.

Study Type : Transgenic Animal Study

Print Options

Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.